PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Market Cap : 5.223M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 5.223M |
| September 03, 2026 | 5.274M |
| September 02, 2026 | 5.161M |
| September 01, 2026 | 5.24M |
| August 31, 2026 | 5.378M |
| August 28, 2026 | 5.529M |
| August 27, 2026 | 5.799M |
| August 26, 2026 | 5.803M |
| August 25, 2026 | 5.793M |
| August 24, 2026 | 5.636M |
| August 21, 2026 | 5.722M |
| August 20, 2026 | 5.521M |
| August 19, 2026 | 5.716M |
| August 18, 2026 | 5.626M |
| August 17, 2026 | 5.821M |
| August 14, 2026 | 5.915M |
| August 13, 2026 | 5.905M |
| August 12, 2026 | 5.877M |
| August 11, 2026 | 5.905M |
| August 10, 2026 | 5.862M |
| August 07, 2026 | 6.335M |
| August 06, 2026 | 6.335M |
| August 05, 2026 | 6.334M |
| August 04, 2026 | 6.452M |
| August 03, 2026 | 6.182M |
| Date | Value |
|---|---|
| July 31, 2026 | 6.184M |
| July 30, 2026 | 6.441M |
| July 29, 2026 | 6.286M |
| July 28, 2026 | 6.334M |
| July 27, 2026 | 6.280M |
| July 24, 2026 | 6.442M |
| July 23, 2026 | 6.493M |
| July 22, 2026 | 6.549M |
| July 21, 2026 | 6.550M |
| July 20, 2026 | 6.692M |
| July 17, 2026 | 6.796M |
| July 16, 2026 | 7.083M |
| July 15, 2026 | 7.573M |
| July 14, 2026 | 7.399M |
| July 13, 2026 | 7.086M |
| July 10, 2026 | 7.477M |
| July 09, 2026 | 7.515M |
| July 08, 2026 | 7.623M |
| July 07, 2026 | 7.633M |
| July 06, 2026 | 7.837M |
| July 02, 2026 | 7.676M |
| July 01, 2026 | 7.955M |
| June 30, 2026 | 8.266M |
| June 29, 2026 | 7.848M |
| June 26, 2026 | 8.263M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 351.15M |
| Amgen, Inc. | 236.37B |
| Anika Therapeutics, Inc. | 278.50M |
| BioCryst Pharmaceuticals, Inc. | 2.542B |
| Imunon, Inc. | 7.372M |
Market Cap Related Metrics
| Price to Book Value | 0.1569 |
| Price | 0.4865 |
| Earnings Yield | -635.3% |